Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 11, 2020Open Access

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

View Full Paper
Ask AI
Bookmark
Share

Authors

UŞUğur ŞahinGoethe University FrankfurtAMAlexander MuikBioNTech (Germany)IVIsabel VoglerBioNTech (Germany)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Şahin et al. (2020) studied this question.

synapsesocial.com/papers/6a19611bb71d9c859388f644https://doi.org/10.1101/2020.12.09.20245175
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New Vaccine Technologies to Combat Outbreak Situations2018 · 599 citations
  2. 2Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies2018 · 293 citations
  3. 3Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection2014 · 461 citations
  4. 4Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies2020 · 1,484 citations
  5. 5Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses2018 · 539 citations